Valuation: Labcorp Holdings Inc.

Capitalization 2.12TCr 1.82TCr 1.69TCr 1.57TCr 2.91TCr 1,82100Cr 3.23TCr 20TCr 7.75TCr 85TCr 7.96TCr 7.8TCr 3,12800Cr P/E ratio 2025 *
21x
P/E ratio 2026 * 18.4x
Enterprise value 2.58TCr 2.2TCr 2.05TCr 1.91TCr 3.53TCr 2,21000Cr 3.92TCr 25TCr 9.4TCr 1,03500Cr 9.66TCr 9.46TCr 3,79600Cr EV / Sales 2025 *
1.85x
EV / Sales 2026 * 1.73x
Free-Float
99.96%
Yield 2025 *
1.14%
Yield 2026 * 1.17%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.58%
1 week-3.20%
Current month-4.91%
1 month-3.97%
3 months+12.72%
6 months+6.63%
Current year+8.85%
More quotes
1 week 247.63
Extreme 247.63
261.81
1 month 247.63
Extreme 247.63
265.72
Current year 209.38
Extreme 209.375
265.72
1 year 205.95
Extreme 205.95
265.72
3 years 191.97
Extreme 191.97
265.72
5 years 170.05
Extreme 170.05
317.17
10 years 97.79
Extreme 97.79
317.17
More quotes
Change 5d. change 1-year change 3-years change Capi.($)
-1.58%-3.20%+21.03%+2.88% 2.12TCr
-0.59%-0.77%+18.44%+122.01% 9.1TCr
-1.28%-2.85%+11.29%-31.60% 8.3TCr
-0.66%-1.06%+44.57%+45.07% 2.78TCr
-0.75%-1.49%-6.36%+38.74% 2.47TCr
-1.96%-3.38%+17.14%+23.62% 1.91TCr
+1.20%+1.54%+31.42%+225.46% 1.61TCr
-1.45%-3.38%+27.72%-2.82% 1.61TCr
-2.56%-6.29%+34.53%+235.23% 1.42TCr
-1.51%-4.67%+16.23%+14.24% 1.34TCr
Average -1.14%-2.37%+21.60%+67.28% 3.27TCr
Weighted average by Cap. -1.02%-1.90%+18.77%+56.08%
See all sector performances

Financials

2025 *2026 *
Net sales 1.39TCr 1.19TCr 1.11TCr 1.03TCr 1.9TCr 1,19300Cr 2.11TCr 13TCr 5.07TCr 56TCr 5.21TCr 5.11TCr 2,04900Cr 1.46TCr 1.25TCr 1.16TCr 1.08TCr 1.99TCr 1,25000Cr 2.22TCr 14TCr 5.31TCr 59TCr 5.46TCr 5.35TCr 2,14600Cr
Net income 92Cr 78Cr 73Cr 68Cr 125.57Cr 7.87TCr 139.55Cr 875.5Cr 334.74Cr 3.69TCr 344.05Cr 336.96Cr 14TCr 106.59Cr 91Cr 85Cr 79Cr 145.91Cr 9.15TCr 162.15Cr 1.02TCr 388.95Cr 4.28TCr 399.77Cr 391.53Cr 16TCr
Net Debt 452.93Cr 387.3Cr 360.76Cr 335.54Cr 619.98Cr 39TCr 689Cr 4.32TCr 1.65TCr 18TCr 1.7TCr 1.66TCr 67TCr 402.71Cr 344.35Cr 320.75Cr 298.33Cr 551.23Cr 35TCr 612.6Cr 3.84TCr 1.47TCr 16TCr 1.51TCr 1.48TCr 59TCr
More financial data * Estimated data
Logo Labcorp Holdings Inc.
Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.
Employees
65,450
More about the company
Date Price Change Volume
12/25/12 249.62 $ -1.58% 10,20,152
10/25/10 253.63 $ -2.10% 13,75,797
09/25/09 259.07 $ +0.63% 5,27,574
08/25/08 257.45 $ -0.16% 6,54,647
07/25/07 257.87 $ -1.53% 5,55,608

Delayed Quote Nyse, July 12, 2025 at 01:30 am IST

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
253.63USD
Average target price
279.06USD
Spread / Average Target
+10.03%
Consensus

Quarterly revenue - Rate of surprise